Clinical Trial Update: A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluating JUVÉDERM VOLUMA XC injectable gel for correcting temple hollowing in adults 22 years and older, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temple Hollowing

Drugs mentioned

• JUVÉDERM VOLUMA XC (hyaluronic acid dermal filler)

Snippet

Sponsor: Allergan | Conditions: Temple Hollowing | Phase 3 | Status: COMPLETED | Results posted: 2024-04-25